Prim-O-glucosylcimifugin attenuates lipopolysaccharide- induced inflammatory response in RAW 264.7 macrophagesWeian Mao, Jian Zhang, Hong Zhang et al.|Pharmacognosy Magazine|2017Cited by 43
Chemotherapeutic drug scavenger-based combination therapy toward treating triple-negative breast cancerQingqing Yin, Linzhi Yan, Yuan Yang et al.|Journal of Nanobiotechnology|2025Cited by 4